MetLife Investment Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

MetLife Investment Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,892	Closed	-$677K	–	2844
2023 Q4	$677K	Buy	+10,892	New	+$271K	﹤0.01%	1516

MetLife Investment Management's RYZB Position: Q1 2024 in Review

MetLife Investment Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 10,892 shares — an estimated $677K sold.

MetLife Investment Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $677K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

MetLife Investment Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
MetLife Investment Management sold 10,892 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $677K.
MetLife Investment Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
MetLife Investment Management's RayzeBio, Inc. Common Stock position peaked at $677K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.